Trial Profile
Phase I study of mRNA 1440
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2016
Price :
$35
*
At a glance
- Drugs MRNA 1440 (Primary)
- Indications Infections
- Focus Adverse reactions
- Sponsors Moderna Therapeutics
- 04 Apr 2016 According to a Moderna Therapeutics media release, the company announced in January that this Phase I study was underway in Europe for mRNA 1440, an infectious disease vaccine in development for an undisclosed target and indication.
- 15 Jan 2016 New trial record